Role of coagulation factors in cerebral venous sinus and cerebral microvascular thrombosis

Neurosurgery

Volumn 66, Issue 3, 2010, Pages 560-565

  Nagai, Mutsumi ^a   Yilmaz, Cigdem Erkuran ^a   Kirchhofer, Daniel ^b   Esmon, Charles T ^c,d,e   MacKman, Nigel ^f   Granger, D Neil ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b GENENTECH INC   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Activated protein C; Brain; Heparin; Thrombosis; Tissue factor

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; ENDOTHELIAL PROTEIN C RECEPTOR; ENZYME ANTIBODY; FERROUS CHLORIDE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; HEPARIN; MONOCLONAL ANTIBODY; THROMBOPLASTIN; TISSUE FACTOR MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTERIOLE; ARTICLE; CEREBRAL ARTERIOLE THROMBOSIS; CEREBRAL VENULE THROMBOSIS; CONTROLLED STUDY; DISEASE MODEL; ENDOTHELIUM CELL; GENE OVEREXPRESSION; MALE; MOUSE; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PHOTOACTIVATION; PRIORITY JOURNAL; SAGITTAL SINUS THROMBOSIS; SUPERIOR SAGITTAL SINUS; THROMBOGENESIS; THROMBOSIS PREVENTION; VENULE; WILD TYPE;

ANIMALS; ANTIGENS, CD; BLOOD COAGULATION FACTORS; CHLORIDES; CRANIAL SINUSES; DEXTRANS; DISEASE MODELS, ANIMAL; FERRIC COMPOUNDS; FLUORESCEIN-5-ISOTHIOCYANATE; HEPARIN; INTRACRANIAL THROMBOSIS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, VIDEO; PROTEIN C; RECEPTORS, CELL SURFACE;

EID: 77649153294     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000365745.49583.FD     Document Type: Article

References (28)

1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371(9624):1612-1623.
2. Pinel C, Wice SM, Hiebert LM. Orally administered heparins prevent arterial thrombosis in a rat model. Thromb Haemost. 2004;91(5):919-926.
3. Rumbaut RE, Slaff DW, Burns AR. Microvascular thrombosis models in venules and arterioles in vivo. Microcirculation. 2005;12(3):259-274.
4. Maxwell KA, Dyck RH. Induction of reproducible focal ischemic lesions in neonatal mice by photothrombosis. Dev Neurosci. 2005;27(2-4):121-126.
5. Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res. 1990;60(4):269-280.
6. Rosenblum WI, El-Sabban F. Platelet aggregation in the cerebral microcirculation: effect of aspirin and other agents. Circ Res. 1977;40(3):320-328.
7. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol. 2005;131(4):417-430.
8. Esmon CT. The impact of the inflammatory response on coagulation. Thromb Res. 2004;114(5-6):321-327.
9. Boekholdt SM, Kramer MH. Arterial thrombosis and the role of thrombophilia. Semin Thromb Hemost. 2007;33(6):588-596.
10. Masuhr F, Mehraein S, Einhäupl K. Cerebral venous and sinus thrombosis. J Neurol. 2004;251(1):11-23.
11. Rahemtullah A, Van Cott EM. Hypercoagulation testing in ischemic stroke. Arch Pathol Lab Med. 2007;131(6):890-901.
12. Rumbaut RE, Randhawa JK, Smith CW, Burns AR. Mouse cremaster venules are predisposed to light/dye-induced thrombosis independent of wall shear rate, CD18, ICAM-1, or P-selectin. Microcirculation. 2004;11(3):239-247.
13. Anthoni C, Russell J, Wood KC, et al. Tissue factor: a mediator of inflammatory cell recruitment, tissue injury, and thrombus formation in experimental colitis. J Exp Med. 2007;204(7):1595-1601.
14. Kim DE, Schellingerhout D, Jaffer FA, Weissleder R, Tung CH. Near-infrared fluorescent imaging of cerebral thrombi and blood-brain barrier disruption in a mouse model of cerebral venous sinus thrombosis. J Cereb Blood Flow Metab. 2005;5(2):226-233.
15. Yoshida H, Russell J, Stokes KY, Yilmaz CE, Esmon CT, Granger DN. Role of the protein C pathway in the extraintestinal thrombosis associated with murine colitis. Gastroenterology. 2008;135(3):882-888.
16. Kirchhofer D, Moran P, Bullens S, Peale F, Bunting S. A monoclonal antibody that inhibits mouse tissue factor function. J Thromb Haemost. 2005;3(5):1098-1099.
17. Mackman N. Triggers, targets and treatments for thrombosis. Nature. 2008; 451(7181):914-918.
18. Lockyer S, Kambayashi J. Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis. J Cardiovasc Pharmacol. 1999;33(5):718-725.
19. Masuhr F, Einhäupl K. Treatment of cerebral venous and sinus thrombosis. Front Neurol Neurosci. 2008;23:132-143.
20. Ferro JM, Canhão P. Acute treatment of cerebral venous and dural sinus thrombosis. Curr Treat Options Neurol. 2008;10(2):126-137.
21. Ferro JM, Canhão P. Complications of cerebral vein and sinus thrombosis. Front Neurol Neurosci. 2008;23:161-171.
22. Azin H, Ashjazadeh N. Cerebral venous sinus thrombosis-clinical features, predisposing and prognostic factors. Acta Neurol Taiwan. 2008;17(2):82-87.
23. Röttger C, Madlener K, Heil M, et al. Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis. Stroke. 2005;36(4):841-846.
24. Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood. 2007;109(8):3161-3172.
25. Ishii H, Salem HH, Bell CE, Laposata EA, Majerus PW. Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain. Blood. 1986;67(2):362-365.
26. Wong VL, Hofman FM, Ishii H, Fisher M. Regional distribution of thrombomodulin in human brain. Brain Res. 1991;556(1):1-5.
27. Mackman N. Role of tissue factor in hemostasis and thrombosis. Blood Cells Mol Dis. 2006;36(2):104-107.
28. Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 2007;27(8):1687-1693.